Top Story

OSN round table: How to become a better femtosecond laser cataract surgeon

December 20, 2014

At the European Society of Cataract and Refractive Surgeons meeting, Ocular Surgery News gathered an international panel of experts to discuss their experiences with femtosecond laser-assisted cataract surgery, with the objective of improving the procedure. The first part of that wide-ranging discussion, moderated by William B. Trattler, MD, is featured in this issue of OSN.

William B. Trattler, MD: We are all experienced femtosecond-assisted cataract surgeons, and each of us has worked with one or more of the available femtosecond laser platforms. The first topic for discussion is educating patients on laser cataract surgery.

CDC/WHO recommend following basic interventions to treat Ebola

December 20, 2014
Currently, there is no FDA-approved vaccine or medicine available to treat Ebola virus, but the CDC recommends for the symptoms and complications of Ebola to be…

CVD care improved across US hospitals from 2009 to 2013

December 20, 2014
The quality of care for patients with MI, HF, stroke and venous thromboembolism has improved across hospitals in the United States in recent years, according to an…

FTC and EC grant clearance for Medtronic acquisition of Covidien

December 20, 2014
Medtronic recently announced it has received clearance from the Federal Trade Commission and conditional clearance from the European Commission for its proposed…
In the Journals

ST2 levels predicted acute GVHD, mortality after double-unit cord blood transplantation

December 19, 2014
High levels of the biomarker suppressor of tumorigenicity 2 at 28 days post-cord blood transplantation independently predicted acute graft-versus-host disease, according…
More News Headlines »
CME
HCV Council 2014 Revisited at AASLD - Critical Appraisal of Data: Recommendations for Clinical Practice in a Rapidly Evolving Therapeutic Landscape

HCV Council 2014 Revisited at AASLD - Critical Appraisal of Data: Recommendations for Clinical Practice in a Rapidly Evolving Therapeutic Landscape

This activity is supported by an educational grant from AbbVie Inc., Gilead Sciences, Inc., and Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Short Subjects

Intravitreal Chemotherapy Provides Control for Massive Vitreous Seeding From Retinoblastoma

Journal of Pediatric Ophthalmology and Strabismus, Volume -2147483648
Online Only, December 12, 2014
Treatment of vitreous seeds in retinoblastoma is challenging because of relatively poor chemotherapeutic drug…
More »
Meeting News Coverage Video
thumbnail for video 3948373717001

VIDEO: Vitreoretinal surgery update for the anterior segment surgeon

December 19, 2014
NEW YORK — John W. Kitchens, MD, discusses misconceptions people have about retina surgery at OSN New York.
More »